Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis

被引：265

作者：

Ballell, Lluis ^{[1
]}

Bates, Robert H. ^{[1
]}

Young, Rob J. ^{[2
]}

Alvarez-Gomez, Daniel ^{[1
]}

Alvarez-Ruiz, Emilio ^{[1
]}

Barroso, Vanessa ^{[1
]}

Blanco, Delia ^{[1
]}

Crespo, Benigno ^{[1
]}

Escribano, Jaime ^{[1
]}

Gonzalez, Ruben ^{[1
]}

Lozano, Sonia ^{[1
]}

Huss, Sophie ^{[1
]}

Santos-Villarejo, Angel ^{[1
]}

Julio Martin-Plaza, Jose ^{[1
]}

Mendoza, Alfonso ^{[1
]}

Jose Rebollo-Lopez, Maria ^{[1
]}

Remuinan-Blanco, Modesto ^{[1
]}

Luis Lavandera, Jose ^{[1
]}

Perez-Herran, Esther ^{[1
]}

Javier Gamo-Benito, Francisco ^{[1
]}

Francisco Garcia-Bustos, Jose ^{[1
]}

Barros, David ^{[1
]}

Castro, Julia P. ^{[1
]}

Cammack, Nicholas ^{[1
]}

机构：

[1] GlaxoSmithKline GSK, Madrid, Spain

[2] GlaxoSmithKline GSK, Med Res Ctr, CSC Med Chem, Stevenage SG1 2NY, Herts, England

来源：

CHEMMEDCHEM | 2013年 / 8卷 / 02期

关键词：

drug discovery; high-throughput screening; open innovation; tuberculosis; MYCOBACTERIUM-TUBERCULOSIS; CHALLENGES; INHIBITORS;

D O I：

10.1002/cmdc.201200428

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

With the aim of fuelling open-source, translational, early-stage drug discovery activities, the results of the recently completed antimycobacterial phenotypic screening campaign against Mycobacterium bovis BCG with hit confirmation in M. tuberculosis H37Rv were made publicly accessible. A set of 177 potent non-cytotoxic H37Rv hits was identified and will be made available to maximize the potential impact of the compounds toward a chemical genetics/proteomics exercise, while at the same time providing a plethora of potential starting points for new synthetic lead-generation activities. Two additional drug-discovery-relevant datasets are included: a) a drug-like property analysis reflecting the latest lead-like guidelines and b) an early lead-generation package of the most promising hits within the clusters identified.

引用

页码：313 / 321

页数：9

共 24 条

[1] High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
Ananthan, Subramaniam
Faaleolea, Ellen R.
Goldman, Robert C.
Hobrath, Judith V.
Kwong, Cecil D.
Laughon, Barbara E.
Maddry, Joseph A.
Mehta, Alka
Rasmussen, Lynn
Reynolds, Robert C.
Secrist, John A., III
Shindo, Nice
Showe, Dustin N.
Sosa, Melinda I.
Suling, William J.
White, E. Lucile
[J]. TUBERCULOSIS, 2009, 89 (05) : 334 - 353
[2] [Anonymous], 2011, GLOBAL TUBERCULOSIS
[3] Multidrug- and extensively drug-resistant tuberculosis: an emerging threat
Berry, M.
Kon, O. M.
[J]. EUROPEAN RESPIRATORY REVIEW, 2009, 18 (114) : 195 - 197
[4] Unfinished business: target-based drug discovery
Brown, David
[J]. DRUG DISCOVERY TODAY, 2007, 12 (23-24) : 1007 - 1012
[5] Unsupervised data base clustering based on Daylight's fingerprint and Tanimoto similarity: A fast and automated way to cluster small and large data sets
Butina, D
[J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 1999, 39 (04): : 747 - 750
[6] Thousands of chemical starting points for antimalarial lead identification
Gamo, Francisco-Javier
Sanz, Laura M.
Vidal, Jaume
de Cozar, Cristina
Alvarez, Emilio
Lavandera, Jose-Luis
Vanderwall, Dana E.
Green, Darren V. S.
Kumar, Vinod
Hasan, Samiul
Brown, James R.
Peishoff, Catherine E.
Cardon, Lon R.
Garcia-Bustos, Jose F.
[J]. NATURE, 2010, 465 (7296) : 305 - U56
[7] The complete genome sequence of Mycobacterium bovis
Garnier, T
Eiglmeier, K
Camus, JC
Medina, N
Mansoor, H
Pryor, M
Duthoy, S
Grondin, S
Lacroix, C
Monsempe, C
Simon, S
Harris, B
Atkin, R
Doggett, J
Mayes, R
Keating, L
Wheeler, PR
Parkhill, J
Barrell, BG
Cole, ST
Gordon, SV
Hewinson, RG
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) : 7877 - 7882
[8] Goldman R., 2005, INNOVATION HAPPENS E
[9] Discovery and validation of new antitubercular compounds as potential drug leads and probes
Goldman, Robert C.
Laughon, Barbara E.
[J]. TUBERCULOSIS, 2009, 89 (05) : 331 - 333
[10] Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]

← 1 2 3 →